AGL 40.40 Increased By ▲ 0.37 (0.92%)
AIRLINK 127.85 Increased By ▲ 0.15 (0.12%)
BOP 6.73 Increased By ▲ 0.12 (1.82%)
CNERGY 4.47 Decreased By ▼ -0.13 (-2.83%)
DCL 8.89 Increased By ▲ 0.10 (1.14%)
DFML 41.47 Decreased By ▼ -0.11 (-0.26%)
DGKC 86.26 Increased By ▲ 0.47 (0.55%)
FCCL 32.59 Increased By ▲ 0.10 (0.31%)
FFBL 64.81 Increased By ▲ 0.78 (1.22%)
FFL 11.61 Increased By ▲ 1.06 (10.05%)
HUBC 113.02 Increased By ▲ 2.25 (2.03%)
HUMNL 14.85 Decreased By ▼ -0.22 (-1.46%)
KEL 5.07 Increased By ▲ 0.19 (3.89%)
KOSM 7.36 Decreased By ▼ -0.09 (-1.21%)
MLCF 40.50 Decreased By ▼ -0.02 (-0.05%)
NBP 61.30 Increased By ▲ 0.25 (0.41%)
OGDC 196.30 Increased By ▲ 1.43 (0.73%)
PAEL 26.93 Decreased By ▼ -0.58 (-2.11%)
PIBTL 7.33 Decreased By ▼ -0.48 (-6.15%)
PPL 154.07 Increased By ▲ 1.54 (1.01%)
PRL 26.22 Decreased By ▼ -0.36 (-1.35%)
PTC 16.17 Decreased By ▼ -0.09 (-0.55%)
SEARL 87.00 Increased By ▲ 2.86 (3.4%)
TELE 7.75 Decreased By ▼ -0.21 (-2.64%)
TOMCL 36.37 Decreased By ▼ -0.23 (-0.63%)
TPLP 8.85 Increased By ▲ 0.19 (2.19%)
TREET 16.59 Decreased By ▼ -1.07 (-6.06%)
TRG 62.10 Increased By ▲ 3.48 (5.94%)
UNITY 28.70 Increased By ▲ 1.84 (6.85%)
WTL 1.35 Decreased By ▼ -0.03 (-2.17%)
BR100 10,140 Increased By 139.8 (1.4%)
BR30 31,425 Increased By 422.5 (1.36%)
KSE100 95,085 Increased By 892.8 (0.95%)
KSE30 29,535 Increased By 333.8 (1.14%)

Drug Regulatory Authority of Pakistan (DRAP) Chairman Dr Sheikh Akhtar Hussain has said the DRAP is restructuring its operation and transforming its regulations on modern scientific basis. The DRAP chairman revealed this while speaking at a meeting with the Lahore chamber of Commerce and Industry (LCCI) office bearers here Tuesday.
Speaking on the occasion LCCI President Malik Tahir Javaid demanded of the Authority to constitute a liaison committee comprising LCCI members and DRAP officials to deal with the issues relating to the pharma industry. In the backdrop of appreciating dollar, the industry particularly consuming imported raw material should be provided relief.
Though the Medical Device Rules-2017 has been simplified yet the businesses dealing in medical devices are facing hardships, he said and stressed the need for their removal. Our members believe that DRAP Act 2012 and SRO 412 have many ambiguities which should be addressed on priority basis, he said.
Furthermore, DRAP needs to ensure clarity in implementations of rules and procedures with regional offices as well. There are still some bottlenecks in the registration of veterinary medicines/vaccines, he said. He pointed out that the DRAP officials raise objections in piecemeal fashion on all the applications submitted by such companies that deal in nutritional products. All objections should be raised at one time so as enable the applicants to remove them, he added. The LCCI chief also emphasized that there must be a stipulated time period for issuance of Form-6 after completion of the formalities.

Copyright Business Recorder, 2018

Comments

Comments are closed.